news Trevi Therapeutics Announces the Initiation of its Phase 2b CORAL Clinical Trial of Haduvio™ for Chronic Cough in Idiopathic Pulmonary Fibrosis (IPF)12/05/2023Trevi Therapeutics Announces Third Quarter 2023 Financial Results and Provides Business Update11/09/2023Trevi Therapeutics Announces the Initiation of its Phase 2a RIVER Clinical Trial of Haduvio™ for Refractory Chronic Cough11/02/2023 VIEW ALL NEWS contact Trevi Therapeutics 195 Church Street, 16th Floor New Haven, CT 06510 map (203) 304-2499 email us
